NUS1 Mutation Causing Ataxia, Myoclonus, and Progressive Encephalopathy
Objective: Describe a rare cause of progressive myoclonus, ataxia, developmental delay Background: 37-year-old man with normal birth but delays in developmental milestones presented for evaluation…Level of glial neurotrophic factor in the blood plasma depending on the duration of Parkinson’s disease
Objective: To study the level of glial neurotrophic factor in the blood plasma depending on the duration of PD. Background: Study of the biochemical aspects…IncobotulinumtoxinA for treating chronic sialorrhea due to Parkinson’s disease and other neurological conditions
Objective: To summarize clinical experience with incobotulinumtoxinA (INCO) for treating chronic sialorrhea due to Parkinson’s disease (PD), atypical parkinsonism, stroke, or traumatic brain injury in…CLINICAL CHARACTERSITICS OF ESSENTIAL TREMOR PATIENTS THAT DEVELOPE PARKINSON´S DISEASE: A COHORT BASED STUDY.
Objective: To elucidate the clinical characteristics of those patients previously diagnosed with essential tremor ( ET ) that finally developed a Parkinson´s disease during the follow…Analyzing the metabolic function of DJ-1 in the pathogenesis of Parkinson`s disease (PD) and Glioblastoma multiforme (GBM)
Objective: In this project, we are comprehensively studying the function of DJ-1 in PD and GBM to better understand its observed role in both, neurodegeneration…Impact of ApoE genotype on cognition in idiopathic and genetic forms of Parkinson’s disease
Objective: The aim of our current report was to assess the impact of Apolipoprotein-E (ApoE) genotype on cognition in idiopathic Parkinson’s disease (PD) patients and…Subcutaneous Foslevodopa/Foscarbidopa in Patients With Advanced Parkinson’s Disease: Results From a Randomized, Double-blind, Double-dummy Phase 3 Trial
Objective: To evaluate the efficacy and safety/tolerability of 24-hour/day continuous subcutaneous infusion (CSCI) of foslevodopa/foscarbidopa (a soluble formulation of levodopa/carbidopa prodrugs) vs oral levodopa/carbidopa in…Neurofilament light chain protein (NfL) is elevated in Essential Tremor
Objective: To investigate neurofilament light chain protein (sNfL) concentrations in serum in Essential Tremor (ET) compared to healthy controls and to assess whether sNfL is…Expression perception and timing in people with Parkinson’s Disease
Objective: To develop a paradigm to test whether the perception of mouth movements is improved when movements occur at a predictable point in time. In…In Silico Study Reveals Cocaine Exposure Modulates Dopamine Neuron Firing Patterns by Inhibiting Small Conductance Calcium Activated Potassium Current
Objective: The neurological reason behind the loss of dopamine neurons causing Parkinson’s disease (PD) is an unsolved mystery. Background: As PD is identified as a…
- « Previous Page
- 1
- …
- 131
- 132
- 133
- 134
- 135
- …
- 153
- Next Page »